Skip to content

Life Sciences

Cleaning validation does not follow the SKU count

  • Life Sciences
  • 1 min read

A product list with 40 SKUs does not need 40 cleaning validations.

Cleaning validation follows the residue and the equipment it is left on. The SKU is a commercial unit, and most of what separates one SKU from the next never touches the granulator.

Take one tablet sold in blisters of 10 and 30 and in a bottle of 100. That is three SKUs and one bulk product. The blender, the press and the coater see the same material each time, so they have one cleaning case.

Across different products, the 2015 text of EU GMP Annex 15 (section 10) allows a worst-case approach. The cleaning procedure is validated on the product that is hardest to clean or most hazardous to carry over, and a scientific rationale should be given for the choice. Solubility, cleanability, toxicity and potency are the criteria it suggests. The impact of new products should also be assessed, so a new product is first compared with the existing worst case.

Strengths are less tidy. Two strengths of one formulation normally sit in one group. A strength with a different excipient or coating may not.

On the packaging line, a change between SKUs is controlled by line clearance under EU GMP Chapter 5: before the next run, the line is checked free of the previous product, materials and documents. Line clearance does not cover everything there. Product-contact parts, such as a blister feeder or filling nozzles, still belong in the cleaning program.

Industries

Related

More on this subject

Concurrent validation is the exceptional route

EU GMP Annex 15 (2015) accepts concurrent validation in exceptional circumstances, where there is a strong benefit-risk ratio for the patient. The decision must be justified, documented in the validation master plan and approved by authorised personnel. A project that is running late does not meet that test.

InsightRead

Cpk 1.33: a convention, and what the GMP texts say instead

A Cpk of 1.33 puts the nearer specification limit 4 standard deviations from the process mean. It is a statistical convention: EU GMP Annex 15 (2015 text) and the FDA guidance of 2011 recommend statistical tools and name no index. With 10 batches the confidence interval is wide, so report the batch count and the interval.

InsightRead

CPV: one abbreviation, two different things

Continued process verification is the FDA's Stage 3: assurance during routine production that the process remains in a state of control. EU GMP Annex 15 (2015) calls it ongoing process verification. Continuous process verification, defined in ICH Q8(R2), is an alternative approach to validation. Write the phrase out and cite its source.

InsightRead